Trinity Biotech (TRIB) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Trinity Biotech plc, a company specializing in human diagnostics and diabetes management including wearable biosensors, has received an extension until October 31, 2024, to demonstrate compliance with Nasdaq’s continued listing requirements regarding the market value of publicly held shares. This follows a deficiency letter from Nasdaq in November 2023 for falling below the minimum threshold. The firm is actively working on regaining compliance to maintain its listing on The Nasdaq Global Select Market.
For further insights into TRIB stock, check out TipRanks’ Stock Analysis page.